Claudio Franceschi CIG Centro Interdipartimentale “L. Galvani” University of Bologna ITALY
description
Transcript of Claudio Franceschi CIG Centro Interdipartimentale “L. Galvani” University of Bologna ITALY
Claudio Franceschi
CIG Centro Interdipartimentale
“L. Galvani”University of Bologna
ITALY
La ricerca per la qualità della vita: la priorità "salute" del 7° Programma Quadro Ferrara, 25 ottobre 2006Aula Magna - Palazzo Bevilacqua Costabili Via Voltapaletto, 11 Nona tappa del "Viaggio della Ricerca in Italia"
Coordinator of the EU Integrated Project GEHA Genetic of Healthy Ageing (2004-2009) devoted to study nuclear and mitochondria genetics of
healthy aging and longevity
• PARTNER OF THE FOLLOWING EU PROJECTS
• GENAGE (1999-2001) coordinatated by Prof. B. Clark, University of Aarhus, Denmark) devoted to the identification of human longevity genes;
• PROTAGE (2001-2003) coordinated by Prof. Bertrand Friguet, University of Paris VII) devoted to the study of proteasome, comprehensive of its activity and genetic polymorphisms in ageing and longevity;
• ECHA (2002-2004) coordinated by Prof. G. De Benectis, University of Calabria) devoted to identification of human frailty and longevity genes;
• FUNCTIONAGE (2002-2004), coordinated by Prof. Olivier Toussaint, University of Namur) devoted to optimize the microchips for the study and diagnosis of the inflammatory status in elderly subjects affected by age-related pathologies.
• T-CIA (2003-2005) coordinated by Prof. Graham Pawelec, University of Tubingen) related to the study of specific immunity T cell-mediated during ageing.
• PROTEOMAGE (2006-2010) coordinatated by Prof. B. Clark, University of Aarhus, Denmark) devoted to study the proteomics of ageing.
• LINKAGE (2005-2008) coordinated by Prof. Olivier Toussaint, University of Namur) devoted to coordinate and fund the study of ageing in Europe.
R&D investments in Europe and the USA
• The proportion of gross national product allocated to R&D is smaller in the UE (1,94 %) than in the USA (2,8 %) and in Japan (2,98 %)
• The 3% objective is still far
• (Lisbonne 2000, Barcelone 2002)Source : Third European Report on S&T Indicators, 2003
– the creation of anthe creation of an "internal market" in research"internal market" in research (free movement of knowledge, researchers and technology)(free movement of knowledge, researchers and technology)
– the restructuring of the European research fabric(improved coordination of national research activities and policies through integration of Europe’s research efforts and capacities)
– the development of athe development of a European research policyEuropean research policy (taking into account other EU and national policies)(taking into account other EU and national policies)
European Research Area -European Research Area - Combining three concepts Combining three concepts *::
* * COM(2002) 565 final, THE EUROPEAN RESEARCH AREA : PROVIDING NEW MOMENTUM
Coordination of Research Coordination of Research
Policy levelopen method of coordinationPolicy support oriented research Legislation (e.g. COM (2004) 178 Directive*) * 3rd country researchers in Europe
Programme levelCREST initiativesERA-NETArticle 169
Project levelNew InstrumentsTraditional Instruments (CAs)
Legal basisLegal basis
“In implementing the multiannual framework programme, the Community may make provision, in agreement with the Member States concerned, for participation in research and development programmes undertaken by several Member States, including participation in the structures created for the execution of those programmes”
Article 169 of the Treaty : :
CARE-LINKAGECOORDINATION OF AGEING
RESEARCH IN EUROPESpetses May 21st 2006
GEHAGEnetics of
HealthyAging
an Integrated Project of EU 6FP
Claudio Franceschi
CIG Centro Interdipartimentale
“L. Galvani”University of Bologna
ITALY
L=E+G+SLongevity = Environment + Genetics + Stocasticity
The equation of longevity
Longevity is a very complex trait
Genetics and Longevity
• Parents of centenarians lived longer than people of the same cohort
• Siblings of centenarians have a “risk” to reach 100 several times higher than that of people of the same cohort
• Offspring of centenarians have a lower mortality and are protected from CVD and cancer
• A strong familiar component of longevity
Genetics and Longevity
The survival advantage of centenarian offspring is not shared by their spouses
despite the fact that they shared the same environment for most of their life
Thus the strong familiar component of longevity is likely a genetic component
and long living sibs should be highly enriched in longevity genes
GEHAGEnetics of Healthy Aging
Integrated Project of EU 6thFP 7.2 M €, 25 Units
Recruitment and Genome Scanning (nuclear and mitochondrial genomes)
of 2650 90+ sibpairs and 2650 young controlscollected in 11 countries
May 1st 2004- April 30th 2009
(www.geha.unibo.it)
GEHAGEnetics of Healthy Aging
Coordinator: Prof. Claudio FranceschiProject Manager: Dr. Alessandra Malavolta
Scientific Manager: Dr. Silvana Valensin
25 partners from 11 European countries and China
The GEHA Consortium
Participant name Short name Country
CIG - University of Bologna, C. Franceschi UNIBO IT
University of Montpellier UM1, J.M. Robine CRLC FR
CAU Kiel Centre for Functional Genomics S. Schreiber, A. Nebel
CAU DE
Foundation Jean Dausset, Hélène Blanché CEPH FR
Istituto Superiore di Sanità, A. Stazi ISS IT
Leiden University Medical Centre, E. Slagboom, R. Westendorp
LUMC NL
Max Planck Institute for Demographic Research, J. Vaupel MPIDR DE
National Hellenic Research Foundation, E. Gonos NHRF GR
National Public Health Institute, L. Peltonen KTL FI
Nencki Istitute for Experimental Biology, E. Sikora NENCKI PL
University of Belfast, QUB, I.M.Rea QUB UK
University of Calabria, G. De Benedictis UNICAL IT
IFOM Institute of Milan, P.G. Pelicci IFOM IT
University of Sassari, L. Deiana UNISS IT
Catholic University of Louvain, M. Poulain UCL BE
Fac. Univ. Notre Dame de la Paix O. Toussaint FUNDP BE
University of Newcastle, T. Kirkwood UNEW UK
University of Southern Denmark, K. Christensen, B. Jeune
SDU DK
Tampere School of Public Health, A. Hervonen TAMPERE FI
Research Innovation s.r.l. A. Leon R&I IT
Istituto Nazionale Ricovero e Cura AnzianiL. Spazzafumo
INRCA IT
University of Aarhus, P. Kristensen UAAR DK
Bejing Genomics Institute, L. Bolund, B. Liu BGI CN
Eppendorf Array Technologies, J. Remacle EAT BE
Institute of Gerontology, V. Bezrukov Inst. Geront. Ukraine
EU Integrated Project supported through Priority 1
(Life Sciences, Genomics and Biotechnology for Health)
of European Union's FP6
Project Number: LSHM-CT-2004-503270
GEHA is the largest project in Europe to study the
genetic determinants of human longevity
GEHA
The aim of GEHA is to identify genes involved in
healthy aging and longevity in humans, which
allow individuals to survive to advanced old age in
good cognitive and physical function and in the
absence of major age-related diseases and
disabilities
The GEHA Consortium involves:
demographers
geriatricians
geneticists
genetic epidemiologists
molecular biologists
bioinfomaticians
statisticians
GEHA : a multi disciplinary project
12 Workpackages (WP)
European Commission
WP1 WP2 WP3
1
WP4 WP5 WP6 WP7 WP8
1 18 17 4 3 12 7
WP9
11
WP10
20
Research Organizationand Standard
Recruitment
Database
Ethics
ASPanalysis
LD Mapping and candidate gene work
mtDNAanalysis
Dataanalysis
Training
Demonstration
Steering Committee
WP11
1
Management
1
Research Organization
WP12
Assessment of Progress and Results
GEHA Infrastructures (www.geha.unibo.it)
DATABASES:1.Phenotype database2.Genotype database3.mtDNA database
Centralized facilities for: - DNA extraction, quality control and banking
-Data analysis, mathematical modelling,advanced statistics
Genetic Platforms
t 0
t 1
t 2
t 3
t 4
t 5
t 6
t 7
t 8
t 9
t 10
1-2 weeks
2-3 weeks
2-3 months
?
?
?
?
?
?
Variable
GEHA DNA Time Schedule
t0
Contact with Trios
Interviewand BloodSampling
Several TriosGrouped
Recruitment Units
Shipmentto KTL
KTL, Helsinki
PID GID
DNA Extraction
t1 t2 t3 t4 t5
DNA QualityCheck
t6
DNA Aliquottingand Plating
t7 t8 t9
Shipment toGenotypingUnits
Genotyping Units
t10
Genetic and mtDNA Analysis
Steering Committee
GEHA Coordinator
Authorization forDNA shipment
Total time = ?
GEHA Infrastructures (www.geha.unibo.it)
GEHA Biobankone of the largest biobank
in Europe on old subjects
GEHA MitoBank at the end of the project the largest
biobank and database on mtDNA in Europe
GEHA Infrastructures (www.geha.unibo.it)
GEHA Biobank
- Coordination among Biobanks in Italy- Coordination among Biobanks in Europe
mtDNA16569 bp
37 genes: 13 OXPHOS subunits 22 tRNA 2 rRNAD-loop or Control Region (16024-576): regulative region
Maternally inherited
Does not Recombine
High mutation rate (particularly the D-loop)
Several mtDNAs per mitochondrion, several mitochondria per cell
Homoplasmic status: same mtDNAs per cell, tissue or organ
Heteroplasmic status: different mtDNAs per cell, tissue
or organ
Wallace D.C.; 2005, Annu Rev. Genet.
mtDNA variants (haplogroups) are not neutraland adaptation to cold climates likely played a major role
Zhang et al, PNAS, 100, 1116-21, 2003
The high incidence of C150T transition in the D-loop of centenarians is an example
of a rare mutation selected through maternal inheritance or somatic event(s)
D-loop mtDNA mutations described in cells and tissues from old people
The design of the GEHA Project allows to perform
both linkage and association studiesaccording to the most advanced
genetic approaches
the GEHA consortium has facilities which allow to use
high throughput (Affymetrix, Illumina)or smaller scale (Sequenom)
platforms
GEHA approach to increase the power of the genetic analysis
H-RASH-RASSIRT3SIRT3 IGF2IGF2
INSINS
THTH
The candidate region 11p15.5The candidate region 11p15.5
PMSD13PMSD13
1.1. The number of samplesThe number of samples1599 individuals from three populations in a case-control association study using existing DNA collections and stringent quality-check
2.2. The number of markersThe number of markersdouble selection of tag- and ht-SNPs, quality check with the CEPH families and the original HapMap data. 356 markers were used for genotyping, with a density comparable to 250’000 markers on the whole genome
3.3. The technologyThe technologyhigh throughput technology genotyping, 384 plate format and 48-plex analysis
CENTENARIANS CONTROLSmales females males females
Central Italy 40 267 221 131
total = 307 total = 352
Germany 76 299 94 282
total = 375 total = 376
South Italy 30 62 48 49
total = 92 total = 97
TOTAL = 774 TOTAL = 825
TOTAL sample = 1599
Sample DesignSample Design